Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tyrosine-ester sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.64e-10	4	82	4	GO:0017067
GeneOntologyMolecularFunction	amine sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.64e-10	4	82	4	GO:0047685
GeneOntologyMolecularFunction	flavonol 3-sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.32e-09	5	82	4	GO:0047894
GeneOntologyMolecularFunction	steroid sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.16e-09	7	82	4	GO:0050294
GeneOntologyMolecularFunction	sulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.28e-08	9	82	4	GO:0043199
GeneOntologyMolecularFunction	aryl sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.44e-08	10	82	4	GO:0004062
GeneOntologyMolecularFunction	3'-phosphoadenosine 5'-phosphosulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.84e-07	13	82	4	GO:0050656
GeneOntologyMolecularFunction	dipeptidyl-peptidase activity	FAP DPP10 DPP8	1.43e-05	12	82	3	GO:0008239
GeneOntologyMolecularFunction	8-hydroxy-2'-deoxyguanosine DNA binding	POT1 WRN	4.98e-05	3	82	2	GO:1905773
GeneOntologyMolecularFunction	telomeric G-quadruplex DNA binding	POT1 WRN	4.98e-05	3	82	2	GO:0061849
GeneOntologyMolecularFunction	sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.68e-05	55	82	4	GO:0008146
GeneOntologyMolecularFunction	exopeptidase activity	AGBL4 FAP DPP10 CPE DPP8	9.02e-05	110	82	5	GO:0008238
GeneOntologyMolecularFunction	linoleic acid epoxygenase activity	CYP2C9 CYP2C18	9.94e-05	4	82	2	GO:0071614
GeneOntologyMolecularFunction	telomeric D-loop binding	POT1 WRN	9.94e-05	4	82	2	GO:0061821
GeneOntologyMolecularFunction	transferase activity, transferring sulphur-containing groups	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.44e-04	74	82	4	GO:0016782
GeneOntologyMolecularFunction	D-loop DNA binding	POT1 WRN	2.47e-04	6	82	2	GO:0062037
GeneOntologyMolecularFunction	oxidized purine DNA binding	POT1 WRN	7.34e-04	10	82	2	GO:0032357
GeneOntologyMolecularFunction	oxidized DNA binding	POT1 WRN	8.94e-04	11	82	2	GO:0032356
GeneOntologyMolecularFunction	G-quadruplex DNA binding	POT1 WRN	1.47e-03	14	82	2	GO:0051880
GeneOntologyMolecularFunction	retinoic acid 4-hydroxylase activity	CYP2C9 CYP2C18	1.47e-03	14	82	2	GO:0008401
GeneOntologyBiologicalProcess	4-nitrophenol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.16e-09	5	82	4	GO:0018960
GeneOntologyBiologicalProcess	3'-phosphoadenosine 5'-phosphosulfate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.31e-07	17	82	4	GO:0050427
GeneOntologyBiologicalProcess	purine ribonucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.31e-07	17	82	4	GO:0034035
GeneOntologyBiologicalProcess	ethanol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.31e-07	17	82	4	GO:0006068
GeneOntologyBiologicalProcess	ethanol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.80e-07	18	82	4	GO:0006067
GeneOntologyBiologicalProcess	primary alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.94e-06	23	82	4	GO:0034310
GeneOntologyBiologicalProcess	estrogen metabolic process	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	1.97e-06	52	82	5	GO:0008210
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3 RB1 ADSS1	2.86e-06	222	82	8	GO:0071466
GeneOntologyBiologicalProcess	sulfation	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.80e-06	27	82	4	GO:0051923
GeneOntologyBiologicalProcess	flavonoid metabolic process	SULT1A4 SULT1A1 SULT1A3	1.68e-05	13	82	3	GO:0009812
GeneOntologyBiologicalProcess	xenobiotic metabolic process	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	2.10e-05	141	82	6	GO:0006805
GeneOntologyBiologicalProcess	alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.63e-05	47	82	4	GO:0046164
GeneOntologyBiologicalProcess	primary alcohol metabolic process	SULT1A2 SULT1A4 CYP2C18 SULT1A1 SULT1A3	6.50e-05	106	82	5	GO:0034308
GeneOntologyBiologicalProcess	hormone metabolic process	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3 CPE	1.43e-04	286	82	7	GO:0042445
GeneOntologyBiologicalProcess	organic hydroxy compound catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.05e-04	73	82	4	GO:1901616
GeneOntologyBiologicalProcess	catechol-containing compound metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.16e-04	74	82	4	GO:0009712
GeneOntologyBiologicalProcess	catecholamine metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.16e-04	74	82	4	GO:0006584
GeneOntologyBiologicalProcess	response to xenobiotic stimulus	TXNIP SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3 RB1 ADSS1	2.36e-04	525	82	9	GO:0009410
GeneOntologyBiologicalProcess	nucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 HACD2	2.57e-04	142	82	5	GO:0033865
GeneOntologyBiologicalProcess	ribonucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 HACD2	2.57e-04	142	82	5	GO:0033875
GeneOntologyBiologicalProcess	purine nucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 HACD2	2.57e-04	142	82	5	GO:0034032
GeneOntologyBiologicalProcess	regulation of synaptic membrane adhesion	MAGI2 PCDH8	3.24e-04	7	82	2	GO:0099179
MousePheno	enlarged gallbladder	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.53e-06	28	64	4	MP:0009342
MousePheno	abnormal gallbladder size	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.30e-05	32	64	4	MP:0020134
MousePheno	abnormal mammary gland morphology	SULT1A2 SULT1A4 SULT1A1 SULT1A3 RB1 DOP1A HR	3.55e-05	201	64	7	MP:0000627
MousePheno	abnormal apocrine gland morphology	SULT1A2 SULT1A4 SULT1A1 SULT1A3 RB1 DOP1A HR	3.55e-05	201	64	7	MP:0013554
MousePheno	abnormal skeletal muscle morphology	TCAF2 SULT1A2 COL12A1 SULT1A4 SULT1A1 SULT1A3 RB1 CMYA5 GTF2IRD1 EEF1A2	9.53e-05	508	64	10	MP:0000759
MousePheno	pale yolk sac	RB1 PAXIP1 MECOM HACD2 GTF2IRD1	1.45e-04	110	64	5	MP:0001722
MousePheno	abnormal gallbladder morphology	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.61e-04	60	64	4	MP:0005084
Domain	-	FAP DPP10 DPP8	1.44e-06	6	79	3	2.140.10.30
Domain	DPPIV_N	FAP DPP10 DPP8	1.44e-06	6	79	3	PF00930
Domain	Peptidase_S9B_N	FAP DPP10 DPP8	1.44e-06	6	79	3	IPR002469
Domain	Peptidase_S9	FAP DPP10 DPP8	1.17e-05	11	79	3	PF00326
Domain	Peptidase_S9	FAP DPP10 DPP8	1.17e-05	11	79	3	IPR001375
Domain	Sulfotransferase_dom	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.58e-05	36	79	4	IPR000863
Domain	Sulfotransfer_1	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.58e-05	36	79	4	PF00685
Domain	Zn_pept	AGBL4 CPE	2.59e-03	18	79	2	SM00631
Domain	SNF	SLC6A7 SLC6A19	2.88e-03	19	79	2	PF00209
Domain	NA_NEUROTRAN_SYMP_1	SLC6A7 SLC6A19	2.88e-03	19	79	2	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A7 SLC6A19	2.88e-03	19	79	2	PS50267
Domain	CARBOXYPEPT_ZN_2	AGBL4 CPE	2.88e-03	19	79	2	PS00133
Domain	Na/ntran_symport	SLC6A7 SLC6A19	2.88e-03	19	79	2	IPR000175
Domain	P-loop_NTPase	MAGI2 SULT1A2 SULT1A1 WRN DYNC1LI1 N4BP2L2 CNP EEF1A2 TDRD12 ADSS1	2.98e-03	848	79	10	IPR027417
Domain	CARBOXYPEPT_ZN_1	AGBL4 CPE	3.19e-03	20	79	2	PS00132
Domain	Peptidase_M14	AGBL4 CPE	4.22e-03	23	79	2	PF00246
Domain	Peptidase_M14	AGBL4 CPE	4.22e-03	23	79	2	IPR000834
Domain	Ig_E-set	TXNIP PLXNC1 SEC63	9.77e-03	104	79	3	IPR014756
Domain	CYCLIN	RB1 CCNA2	1.13e-02	38	79	2	SM00385
Domain	-	RB1 CCNA2	1.24e-02	40	79	2	1.10.472.10
Pathway	KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.58e-09	5	61	4	M47807
Pathway	KEGG_SULFUR_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.20e-07	13	61	4	M18256
Pathway	WP_ESTROGEN_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.19e-06	22	61	4	MM15888
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.64e-06	23	61	4	MM14597
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.16e-06	24	61	4	M16289
Pathway	REACTOME_PARACETAMOL_ADME	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.33e-05	39	61	4	MM15695
Pathway	WP_RETINOL_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.78e-05	44	61	4	MM15851
Pathway	WP_SULFATION_BIOTRANSFORMATION_REACTION	SULT1A2 SULT1A4 SULT1A1	5.02e-05	17	61	3	M39483
Pathway	REACTOME_PARACETAMOL_ADME	SULT1A4 SULT1A1 SULT1A3	2.60e-04	29	61	3	M45015
Pathway	WP_ARYLAMINE_METABOLISM	SULT1A2 SULT1A1	2.73e-04	6	61	2	M39437
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	3.66e-04	220	61	6	M10320
Pathway	KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482	RB1 CCNA2	6.50e-04	9	61	2	M47578
Pubmed	Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	24318996
Pubmed	Molecular cloning of cDNA encoding the phenol/aryl form of sulfotransferase (mSTp1) from mouse liver.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	8424956
Pubmed	Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	33414449
Pubmed	Steroid sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	8943792
Pubmed	Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	8288252
Pubmed	A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	12390022
Pubmed	Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.01e-11	4	83	4	25370010
Pubmed	Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-10	5	83	4	11389699
Pubmed	Hemoglobin adducts of furfuryl alcohol in genetically modified mouse models: Role of endogenous sulfotransferases 1a1 and 1d1 and transgenic human sulfotransferases 1A1/1A2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-10	5	83	4	29908303
Pubmed	Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-10	5	83	4	24802129
Pubmed	The effect of knockout of sulfotransferases 1a1 and 1d1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-10	5	83	4	25053625
Pubmed	Chromosomal localization of three vacuolar-H+ -ATPase 16 kDa subunit (ATP6V0C) genes in the murine genome.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-09	7	83	4	12438748
Pubmed	The mouse Plk gene: structural characterization, chromosomal localization and identification of a processed Plk pseudogene.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-09	7	83	4	9370299
Pubmed	Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.10e-09	8	83	4	10594240
Pubmed	The gene encoding the heart/muscle isoform of cytochrome c oxidase subunit VIII maps to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	9166597
Pubmed	Msx3: a novel murine homologue of the Drosophila msh homeobox gene restricted to the dorsal embryonic central nervous system.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	8887328
Pubmed	Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	23207770
Pubmed	Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	8468045
Pubmed	Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	19548878
Pubmed	Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	9060415
Pubmed	Structure of the human gene (COX6A2) for the heart/muscle isoform of cytochrome c oxidase subunit VIa and its chromosomal location in humans, mice, and cattle.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.76e-09	9	83	4	9177785
Pubmed	Rat phenol-preferring sulfotransferase genes (Stp and Stp2): localization to mouse chromosomes 7 and 17.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.26e-09	10	83	4	7601475
Pubmed	Localization of the murine cholecystokinin A and B receptor genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.82e-09	11	83	4	7613026
Pubmed	Sulfotransferases in the bioactivation of xenobiotics.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.82e-09	11	83	4	11154739
Pubmed	Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.82e-09	11	83	4	8954725
Pubmed	Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.82e-09	11	83	4	9034160
Pubmed	Sulfotransferases: genetics and role in toxicology.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.82e-09	11	83	4	10720750
Pubmed	Identification of two human brain aryl sulfotransferase cDNAs.	SULT1A4 SULT1A1 SULT1A3	1.31e-08	3	83	3	8363592
Pubmed	A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.	SULT1A4 SULT1A1 SULT1A3	1.31e-08	3	83	3	9855620
Pubmed	Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16.	SULT1A2 SULT1A1 SULT1A3	1.31e-08	3	83	3	8912648
Pubmed	Identification of four chromosomal loci determining obesity in a multifactorial mouse model.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.47e-08	12	83	4	7706460
Pubmed	PHR1 encodes an abundant, pleckstrin homology domain-containing integral membrane protein in the photoreceptor outer segments.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.12e-08	13	83	4	10585447
Pubmed	Structural and chemical profiling of the human cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.12e-08	13	83	4	17425406
Pubmed	cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.03e-08	15	83	4	1741163
Pubmed	Interaction of the Brain-Selective Sulfotransferase SULT4A1 with Other Cytosolic Sulfotransferases: Effects on Protein Expression and Function.	SULT1A4 SULT1A1 SULT1A3	5.23e-08	4	83	3	32152050
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.99e-08	18	83	4	20056724
Pubmed	Inactivation of Wt1 causes pre-granulosa cell to steroidogenic cell transformation and defect of ovary development†.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.75e-07	21	83	4	32301970
Pubmed	Evaluation of candidate genes for cholinesterase activity in farmworkers exposed to organophosphorus pesticides: association of single nucleotide polymorphisms in BCHE.	SULT1A2 CYP2C9 CYP2C18 SULT1A1	7.88e-07	30	83	4	20529763
Pubmed	An interspecific backcross linkage map of the proximal half of mouse chromosome 14.	RB1 GZMH HR	1.55e-06	10	83	3	1971251
Pubmed	Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.	SULT1A2 SULT1A1 SULT1A3	1.55e-06	10	83	3	11535246
Pubmed	Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.	SULT1A1 SULT1A3	5.63e-06	2	83	2	14871892
Pubmed	Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population.	SULT1A2 SULT1A1	5.63e-06	2	83	2	23358261
Pubmed	Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines.	CYP2C9 CYP2C18	5.63e-06	2	83	2	22918969
Pubmed	Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN.	POT1 WRN	5.63e-06	2	83	2	20008939
Pubmed	Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.	SULT1A1 SULT1A3	5.63e-06	2	83	2	38069221
Pubmed	Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.	SULT1A2 SULT1A1	5.63e-06	2	83	2	11207031
Pubmed	Differential roles of human monoamine (M)-form and simple phenol (P)-form phenol sulfotransferases in drug metabolism.	SULT1A1 SULT1A3	5.63e-06	2	83	2	12761191
Pubmed	Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population.	SULT1A2 SULT1A1	5.63e-06	2	83	2	20936502
Pubmed	Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18.	CYP2C9 CYP2C18	5.63e-06	2	83	2	8333835
Pubmed	Crystal structure of human catecholamine sulfotransferase.	SULT1A4 SULT1A3	5.63e-06	2	83	2	10543947
Pubmed	Primary structures and properties of two related forms of aryl sulfotransferases in human liver.	SULT1A2 SULT1A1	5.63e-06	2	83	2	7581483
Pubmed	Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.	SULT1A4 SULT1A3	5.63e-06	2	83	2	29705271
Pubmed	Phylogenomic approaches to common problems encountered in the analysis of low copy repeats: the sulfotransferase 1A gene family example.	SULT1A4 SULT1A3	5.63e-06	2	83	2	15752422
Pubmed	Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2.	SULT1A2 SULT1A1	5.63e-06	2	83	2	20417180
Pubmed	Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2.	SULT1A2 SULT1A1	5.63e-06	2	83	2	10762004
Pubmed	Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization.	SULT1A4 SULT1A3	5.63e-06	2	83	2	8117269
Pubmed	Localisation of aryl sulfotransferase expression in human tissues using hybridisation histochemistry and immunohistochemistry.	SULT1A2 SULT1A1	5.63e-06	2	83	2	9566757
Pubmed	Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.	SULT1A1 SULT1A3	5.63e-06	2	83	2	8093002
Pubmed	The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese.	SULT1A2 SULT1A1	5.63e-06	2	83	2	12469224
Pubmed	Fission yeast Pot1 and RecQ helicase are required for efficient chromosome segregation.	POT1 WRN	5.63e-06	2	83	2	21098121
Pubmed	Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.	SULT1A4 SULT1A3	5.63e-06	2	83	2	31145702
Pubmed	Sulfation of "estrogenic" alkylphenols and 17beta-estradiol by human platelet phenol sulfotransferases.	SULT1A2 SULT1A3	5.63e-06	2	83	2	10617600
Pubmed	Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.	SULT1A2 SULT1A1	5.63e-06	2	83	2	16133548
Pubmed	Structural similarity and diversity of sulfotransferases.	SULT1A2 SULT1A1	5.63e-06	2	83	2	8033246
Pubmed	A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.	SULT1A2 CYP2C9 SULT1A1	7.18e-06	16	83	3	12419832
Pubmed	Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form.	SULT1A1 SULT1A3	1.69e-05	3	83	2	7695643
Pubmed	Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.	RB1 GTF2IRD1	1.69e-05	3	83	2	9426068
Pubmed	Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.	RB1 CCNA2	1.69e-05	3	83	2	9219533
Pubmed	Comprehensive Analysis of Gene Expression Profiles and DNA Methylome reveals Oas1, Ppie, Polr2g as Pathogenic Target Genes of Gestational Diabetes Mellitus.	POLR2G OAS1	1.69e-05	3	83	2	30389953
Pubmed	The human CYP2C locus: a prototype for intergenic and exon repetition splicing events.	CYP2C9 CYP2C18	1.69e-05	3	83	2	10704292
Pubmed	Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis.	SULT1A1 SULT1A3	1.69e-05	3	83	2	26067475
Pubmed	Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities.	CYP2C9 CYP2C18	1.69e-05	3	83	2	15102943
Pubmed	Telomeric D-loops containing 8-oxo-2'-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1.	POT1 WRN	1.69e-05	3	83	2	19734539
Pubmed	Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2).	SULT1A2 SULT1A1	1.69e-05	3	83	2	18259693
Pubmed	SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA.	KHDRBS1 PUM2	1.69e-05	3	83	2	29386330
Pubmed	POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates.	POT1 WRN	1.69e-05	3	83	2	16030011
Pubmed	Structure of human estrogen and aryl sulfotransferase gene. Two mRNA species issued from a single gene.	SULT1A4 SULT1A3	1.69e-05	3	83	2	7961757
Pubmed	In silico mechanistic profiling to probe small molecule binding to sulfotransferases.	SULT1A1 SULT1A3	1.69e-05	3	83	2	24039991
Pubmed	Interaction between human cyclin A and adenovirus E1A-associated p107 protein.	RB1 CCNA2	1.69e-05	3	83	2	1532458
Pubmed	Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.	SULT1A2 SULT1A1	1.69e-05	3	83	2	26455829
Pubmed	Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.	DPP10 DPP8	1.69e-05	3	83	2	12662155
Pubmed	3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization.	RB1 CCNA2	1.69e-05	3	83	2	15828833
Pubmed	Mechanism of Werner DNA helicase: POT1 and RPA stimulates WRN to unwind beyond gaps in the translocating strand.	POT1 WRN	1.69e-05	3	83	2	19262689
Pubmed	Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily.	CYP2C9 CYP2C18	1.69e-05	3	83	2	8095407
Pubmed	Maps from two interspecific backcross DNA panels available as a community genetic mapping resource.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.74e-05	72	83	4	8075499
Pubmed	Human phenol sulfotransferase STP2 gene: molecular cloning, structural characterization, and chromosomal localization.	SULT1A2 SULT1A1	3.37e-05	4	83	2	8661000
Pubmed	Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily.	CYP2C9 CYP2C18	3.37e-05	4	83	2	2009263
Pubmed	Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.	FAP DPP8	3.37e-05	4	83	2	20043068
Pubmed	Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population.	CYP2C9 CYP2C18	3.37e-05	4	83	2	21798861
Pubmed	Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.	RB1 CCNA2	3.37e-05	4	83	2	15306814
Pubmed	Structural and functional characterization of the HPV16 E7 protein expressed in bacteria.	RB1 CCNA2	3.37e-05	4	83	2	8245034
Pubmed	A family of human zinc finger proteins that bind methylated DNA and repress transcription.	ZBTB38 ZBTB4	3.37e-05	4	83	2	16354688
Pubmed	Biochemistry and molecular biology of the human CYP2C subfamily.	CYP2C9 CYP2C18	3.37e-05	4	83	2	7704034
Pubmed	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.	CYP2C9 SULT1A1	3.37e-05	4	83	2	15632378
Pubmed	B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.	RB1 CCNA2	3.37e-05	4	83	2	12439743
Pubmed	Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.	CYP2C9 CYP2C18	3.37e-05	4	83	2	23755828
Pubmed	Genetic modifiers interact with Cpe(fat) to affect body weight, adiposity, and hyperglycemia.	CPE HR	3.37e-05	4	83	2	15870393
Pubmed	Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.	CYP2C9 CYP2C18	3.37e-05	4	83	2	19706858
Pubmed	Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development.	KHDRBS1 ZKSCAN2 CNP	4.11e-05	28	83	3	38324473
Pubmed	Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): A systematic analysis.	SULT1A2 SULT1A1	5.60e-05	5	83	2	26169578
Interaction	SULT1C2 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3 POT1	1.03e-08	19	81	5	int:SULT1C2
Interaction	SULT4A1 interactions	SULT1A2 SULT1A1 SULT1A3 POT1	2.42e-06	24	81	4	int:SULT4A1
Interaction	SULT1A3 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.42e-06	24	81	4	int:SULT1A3
Interaction	SULT1B1 interactions	SULT1A4 SULT1A3 POT1	3.45e-06	8	81	3	int:SULT1B1
Interaction	SULT1A1 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3 TMOD3	7.35e-06	67	81	5	int:SULT1A1
Interaction	SULT1A4 interactions	SULT1A4 SULT1A1 SULT1A3	2.21e-05	14	81	3	int:SULT1A4
Interaction	SULT1A2 interactions	SULT1A2 SULT1A1 SULT1A3	5.79e-05	19	81	3	int:SULT1A2
Cytoband	16p12.1	SULT1A2 SULT1A1 ZKSCAN2	1.23e-05	25	82	3	16p12.1
GeneFamily	Sulfotransferases, cytosolic	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.50e-08	14	51	4	762
GeneFamily	CD molecules\|DASH family	FAP DPP10 DPP8	7.34e-07	7	51	3	1205
Coexpression	VERNOCHET_ADIPOGENESIS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.01e-07	24	82	4	MM1317
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500	FAP COL8A1 COL12A1 DPP10 KHDRBS1 SULT1A1 MECOM HACD2 PLOD2 PCDH8	4.52e-06	421	81	10	gudmap_developingKidney_e15.5_Peripheral blastema_500
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500	FAP COL8A1 DPP10 SULT1A1 MECOM HACD2 PLOD2	1.38e-05	206	81	7	gudmap_developingKidney_e15.5_Peripheral blastema_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000	FAP COL8A1 DPP10 SULT1A1 MECOM HACD2 PLOD2	3.14e-05	234	81	7	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	FAP COL8A1 COL12A1 DPP10 KHDRBS1 SULT1A1 PLXNC1 MECOM HACD2 SEC63 PLOD2 PCDH8	6.13e-05	819	81	12	gudmap_developingKidney_e15.5_Peripheral blastema_1000
ToppCell	facs-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 FAP COL8A1 COL12A1 CPE PLOD2	1.79e-06	198	82	6	71e847e8c24744d6df4a960348ad2ecf310373b4
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 FAP COL8A1 COL12A1 CPE	3.65e-06	126	82	5	c3261ea8726400de87f1c8a5a5134ba2b2884f66
ToppCell	droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 CSGALNACT2 GPR35 PPP1R42 ADSS1	8.55e-06	150	82	5	34774b015adecc2be56a471fda8994e89a6ad93e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDSN MECOM CMYA5 GTF2IRD1 CCNA2	9.41e-06	153	82	5	79c4f4ccdc8249c8461075c73491bc3b2d13344a
ToppCell	21-Trachea-Epithelial-Submucosal_gland_basal\|Trachea / Age, Tissue, Lineage and Cell class	COL8A1 COL12A1 NPAP1 FGF1 HR	1.13e-05	159	82	5	4f670b57b8d3b090ea2f1aafe15baf93cb7ef146
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	1.36e-05	165	82	5	731147b4337fd0de4383dc8170b4f9ccd98caec6
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD4 MAGI2 COL8A1 CPE PLOD2	1.52e-05	169	82	5	58e22f9119240664515fe91ca53812611a8f17d6
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 HACD2 PPP1R42	1.61e-05	171	82	5	95e87987a2332fa646849fb0de785f1e0b8a07dd
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 HACD2 PPP1R42	1.61e-05	171	82	5	36657e277aad75c4f157c1726c48e09b5836cf37
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	DPP10 GCAT MECOM PLOD2 PPP1R42	1.61e-05	171	82	5	3ecd0a074344179c57eb2d9a857ba594904d00fa
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 HACD2 CCNA2	1.90e-05	177	82	5	b41e975e8368e2618b015be095efe8c0e001c78b
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 HACD2 CCNA2	1.90e-05	177	82	5	15d1de38e4f1a0d4a786d83ee92240f44bdff006
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	1.95e-05	178	82	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	IIH-matDC\|IIH / Condition, Cell_class and T cell subcluster	FAP COL8A1 COL12A1 CPE PLOD2	2.01e-05	179	82	5	5999c85ce3bab5309ff1ed154be7e32b037750b1
ToppCell	IIH-matDC-\|IIH / Condition, Cell_class and T cell subcluster	FAP COL8A1 COL12A1 CPE PLOD2	2.01e-05	179	82	5	46074b2781ed79e2979428b3ec81504621d3903c
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.12e-05	181	82	5	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.17e-05	182	82	5	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.17e-05	182	82	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.35e-05	185	82	5	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.35e-05	185	82	5	3e39a3cb534dfe2301930f3e2f7e8cefb522c158
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.35e-05	185	82	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	TXNIP ZBTB38 GZMH OAS1 DTHD1	2.48e-05	187	82	5	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.48e-05	187	82	5	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI2 DNAH17 CPE RP1 GTF2IRD1	2.48e-05	187	82	5	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	THSD4 AGBL4 CMYA5 GTF2IRD1 PPP1R42	2.54e-05	188	82	5	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAGI2 COL12A1 CPE PLOD2 C3orf49	2.54e-05	188	82	5	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.54e-05	188	82	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.54e-05	188	82	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.60e-05	189	82	5	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.60e-05	189	82	5	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TXNIP ZBTB38 GZMH OAS1 DTHD1	2.67e-05	190	82	5	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TXNIP ZBTB38 GZMH OAS1 DTHD1	2.67e-05	190	82	5	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP10 SLC26A9 CPE PCDH8 EEF1A2	2.67e-05	190	82	5	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP10 SLC26A9 CPE PCDH8 EEF1A2	2.67e-05	190	82	5	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TXNIP ZBTB38 GZMH OAS1 DTHD1	2.67e-05	190	82	5	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP10 SLC26A9 CPE PCDH8 EEF1A2	2.67e-05	190	82	5	a9a705455019e28d655636de73b07540798f82e6
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TXNIP ZBTB38 GZMH OAS1 DTHD1	2.67e-05	190	82	5	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	THSD4 AGBL4 CMYA5 GTF2IRD1 PPP1R42	2.74e-05	191	82	5	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	droplet-Heart\|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TXNIP SULT1A1 ZBTB4 MECOM EEF1A2	2.81e-05	192	82	5	67a7e07a11091120edbccf739836235c422ec9c6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AGBL4 NPAP1 MECOM GTF2IRD1	2.81e-05	192	82	5	2510f22197502f60fd266b7f42eff040f25b8ae7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 AGBL4 NPAP1 MECOM GTF2IRD1	2.81e-05	192	82	5	e8e316f396834bcd34843e56e1d86f310fd6aada
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FAP COL8A1 COL12A1 FGF1 CPE	2.88e-05	193	82	5	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	AGBL4 RP1 SPAG17 DTHD1 PPP1R42	2.88e-05	193	82	5	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MAGI2 FAP COL8A1 COL12A1 PLOD2	3.18e-05	197	82	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AGBL4 NPAP1 RP1 SPAG17 DTHD1	3.18e-05	197	82	5	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	COVID_vent-Lymphocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PDIA4 TXNIP ZBTB38 GZMH IRF4	3.25e-05	198	82	5	ee80f647317377081b4bd194ee2801f556b3a53b
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	FAP COL8A1 COL12A1 FGF1 PLOD2	3.25e-05	198	82	5	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	FAP COL8A1 COL12A1 CPE PLOD2	3.25e-05	198	82	5	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	COL8A1 DPP10 FGF1 CPE PLOD2	3.33e-05	199	82	5	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	FAP COL8A1 COL12A1 FGF1 PLOD2	3.33e-05	199	82	5	f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD4 FAP COL8A1 COL12A1 CPE	3.41e-05	200	82	5	be527df943a8cedc6452ecef3cafc282db34ceb8
ToppCell	mLN-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	PRPSAP2 PRAM1 GPR35 NIPSNAP1 DYNC1LI1	3.41e-05	200	82	5	e3f7852aaa26a9b3e626d85e40afde799e873045
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	TXNIP ZBTB38 GZMH OAS1 DTHD1	3.41e-05	200	82	5	b7f80b2db07119069fbf3d245cf1ad79e8648bab
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD4 FAP COL8A1 COL12A1 CPE	3.41e-05	200	82	5	d254f6634895486f81d7a8b6f006fbc2679eaa5b
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD4 FAP COL8A1 COL12A1 CPE	3.41e-05	200	82	5	8e41a484038216f0c2ad258fd46c0e702a4bb8bf
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 FAP COL8A1 COL12A1 CPE	3.41e-05	200	82	5	c935caef2988f165e96d8f1ef99ae8963ab9377f
ToppCell	Epithelial-B_(AT1-AT2-progenitors)\|World / shred on cell class and cell subclass (v4)	SPRR3 FGF1 MECOM SLC26A9	1.53e-04	146	82	4	4511916904c1fac252cb68e871b782207f8137b3
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	GZMH TMEM216 POLR2G CMYA5	1.57e-04	147	82	4	b2196046656157d7fcf5b5d1cec7bf521b1e5d8e
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GZMH TMEM216 POLR2G CMYA5	1.65e-04	149	82	4	4034805c4eefb8bfb3a357273ccbdb77283ea4a5
ToppCell	droplet-Liver-LIVER_HEP-30m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULT1A1 GCAT NIPSNAP1 FGF1	1.70e-04	150	82	4	42fd42a0be918a77aca4e0c91f068bdd5a5d9286
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAP COL8A1 PLCXD2 TDRD12	1.70e-04	150	82	4	7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAP COL8A1 PLCXD2 TDRD12	1.70e-04	150	82	4	e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee
ToppCell	droplet-Liver-LIVER_HEP-30m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULT1A1 GCAT NIPSNAP1 FGF1	1.70e-04	150	82	4	c2fcdd62ec85cbf9783a525cd7556e16a1e55cd8
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	AGBL4 MECOM RP1 SPAG17	1.74e-04	151	82	4	8216462e723fec2797387929dde095370947e10a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLCXD2 GZMH DTHD1 CCNA2	1.78e-04	152	82	4	669d8f12fdb110ed72f4e5348b7b5350144a061c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPRR3 SLC6A19 RP1 GCKR	1.83e-04	153	82	4	499670e716fc85ce76630fc813cec86f8419f2a1
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NIPSNAP1 OAS1 DTHD1 CCNA2	1.83e-04	153	82	4	c4dcdcaa672929c1da870e9fb8ada1bb030ad12f
ToppCell	343B-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	THSD4 TCAF2 CPNE3 DTHD1	1.88e-04	154	82	4	71d33b5dbfab5820e3daddb01806a69116ba8008
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CDSN MECOM CMYA5 GTF2IRD1	2.12e-04	159	82	4	50d951cf27a571c0c5002003c16fbc370fa17eb1
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DUXA PLCXD2 GZMH IRF4	2.17e-04	160	82	4	50d4f867d021abcfeb49e6812bcfd5bb57466a31
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CYP2C18 NPAP1 MECOM CMYA5	2.17e-04	160	82	4	7064af50fc10e3ea03badf415306222b74db0f95
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DUXA PLCXD2 GZMH IRF4	2.17e-04	160	82	4	0f15f895f11dcabb73df79b26bfc4947f38435a7
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DUXA PLCXD2 GZMH IRF4	2.17e-04	160	82	4	7d004bfe42707605b3851cb2319126acda4d4802
ToppCell	droplet-Thymus-nan-21m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULT1A1 GPR35 PPP1R42 HR	2.22e-04	161	82	4	441ebd3c029861d833fbcf8a68fc740d9de8ef2f
ToppCell	Severe-CD8+_T\|World / Disease group and Cell class	TXNIP GZMH DTHD1	2.24e-04	64	82	3	3e7ede6ec5d8b9c4fc6f3aa8fda91fd9b763ef18
ToppCell	Ciliated_cells-B-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	RP1 SPAG17 DTHD1 PPP1R42	2.39e-04	164	82	4	fd30c55d0d75ef8b9396435d836187168095152b
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AGBL4 PRAM1 GZMH WRN	2.39e-04	164	82	4	30c3c25b05a403a509b2e755c2f0878fecb10a02
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI2 COL12A1 CPE GTF2IRD1	2.39e-04	164	82	4	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	PRAM1 GZMH DTHD1 TDRD12	2.39e-04	164	82	4	92fb94492fc2b683e9d50a9db6f01d23c194b0e4
ToppCell	droplet-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 PPP1R42	2.44e-04	165	82	4	3cdb921f5b9facf04f81995d5641ac14ef3dbb6f
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP COL12A1 GCKR CMYA5	2.56e-04	167	82	4	805129f887078340b260aa136b0ba19f2bd6ea03
ToppCell	droplet-Spleen-nan-21m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 PPP1R42	2.56e-04	167	82	4	cfcd72292c733cdb18c92fdb61b68f6806d22c8c
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP COL12A1 GCKR CMYA5	2.56e-04	167	82	4	31cf8bf2eb523f6e7e319620648ff37fc09e2601
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAP COL12A1 GCKR CMYA5	2.56e-04	167	82	4	3acb18428d1d33ad430c2fd031b1a91baee3c01d
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 PPP1R42	2.61e-04	168	82	4	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	Immune_cells-Neutrophils\|Immune_cells / Lineage and Cell class	PRAM1 TMEM216 CPNE3 PPP1R42	2.61e-04	168	82	4	3539f802fe0143da1462df0618f78f9f15143f71
ToppCell	15-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	RP1 SPAG17 DTHD1 PPP1R42	2.67e-04	169	82	4	425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM216 CPE EEF1A2 TDRD12	2.67e-04	169	82	4	1558606be0a8bcd4fd0ce609701a1411e4ca2f9f
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM216 CPE EEF1A2 TDRD12	2.67e-04	169	82	4	1b2354de1ce4080118d9f01e7c5fd6079e705125
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AGBL4 RP1 SPAG17 DTHD1	2.67e-04	169	82	4	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	COL8A1 COL12A1 MECOM RP1	2.74e-04	170	82	4	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSGALNACT2 PLXNC1 TMEM216 ADSS1	2.80e-04	171	82	4	355a27ea88410a84210f7e4298c7c4f90cf2f8a9
ToppCell	Ciliated_cells-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	RP1 SPAG17 DTHD1 PPP1R42	2.86e-04	172	82	4	187ae91148d293537afc77e10da2b64302322224
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A7 FAP COL12A1 PLOD2	2.86e-04	172	82	4	18bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 PLXNC1 CPNE3 PPP1R42	2.86e-04	172	82	4	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDIA4 ZBTB38 IRF4 ADSS1	2.92e-04	173	82	4	60e427f6c7d953cef5f692043670ff0b49cdce72
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	DPP10 GCAT MECOM PLOD2	2.99e-04	174	82	4	6d9bdf4d28ff8ebb66ffd1ccdd6a4fe9440a83f3
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDIA4 ZBTB38 IRF4 ADSS1	2.99e-04	174	82	4	c92eec5a14ca5269673582dd115ead8516e64c3e
ToppCell	droplet-Marrow-nan-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAM1 TMEM216 CPNE3 PPP1R42	2.99e-04	174	82	4	4b749ac9f05776c0c56b74daca833bd0b5704299
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	COL8A1 COL12A1 MECOM RP1	2.99e-04	174	82	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
Drug	dopamine-4-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.42e-09	7	82	4	CID000123932
Drug	2-naphthylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.42e-09	7	82	4	CID000074428
Drug	2-iodo-4-azidophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.42e-09	7	82	4	CID003035977
Drug	luciferyl sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.42e-09	7	82	4	CID011953812
Drug	2-iodophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.08e-08	8	82	4	CID000010784
Drug	dopamine 3-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.08e-08	8	82	4	CID000122136
Drug	6-anilino-2-thiouracil	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.08e-08	8	82	4	CID003037707
Drug	9-hydroxybenzo(a)pyrene	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	3.63e-08	53	82	6	CID000028598
Drug	A2'p5'A2'p5'A	SULT1A2 SULT1A4 SULT1A1 SULT1A3 OAS1	8.45e-08	31	82	5	CID000122642
Drug	acetaminophen sulfate	SLC6A7 SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.45e-08	31	82	5	CID000083939
Drug	EM-139	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.09e-07	13	82	4	CID000131427
Drug	naphthalenemethanol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.52e-07	14	82	4	CID000020908
Drug	deoxoestrone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.52e-07	14	82	4	CID000005888
Drug	arylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.07e-07	15	82	4	CID000074426
Drug	cyclobenzaprine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.07e-07	15	82	4	CID000002895
Drug	mefenamic acid	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	2.13e-07	37	82	5	CID000004044
Drug	A-44	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.75e-07	16	82	4	CID000120353
Drug	benzilic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.59e-07	17	82	4	CID000006463
Drug	AC1Q6OHG	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.81e-07	19	82	4	CID000115063
Drug	pedunculagin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.81e-07	19	82	4	CID000442688
Drug	PLP-Glu	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.25e-07	20	82	4	CID000444293
Drug	sulfamethazine	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	8.12e-07	48	82	5	CID000005327
Drug	N-hydroxy-2-aminofluorene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.93e-07	21	82	4	CID000005895
Drug	p-nitroanisole	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	1.01e-06	92	82	6	CID000007485
Drug	2-naphthol	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	1.08e-06	93	82	6	CID000008663
Drug	MeA alpha C	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.09e-06	22	82	4	CID000062244
Drug	AABSSN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.09e-06	22	82	4	CID005464134
Drug	taselin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.31e-06	23	82	4	CID000023846
Drug	minoxidil	SULT1A2 SULT1A4 SULT1A1 SULT1A3 PLOD2	1.47e-06	54	82	5	CID000004201
Drug	Phosphoadenosine Phosphosulfate	SULT1A2 SULT1A1 SULT1A3	1.56e-06	7	82	3	ctd:D010724
Drug	AalphaC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.57e-06	24	82	4	CID000062805
Drug	MeIQx	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	1.62e-06	55	82	5	CID000062275
Drug	AzMC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.87e-06	25	82	4	CID000064986
Drug	minoxidil sulphate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.87e-06	25	82	4	CID000004202
Drug	2-pentanone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.87e-06	25	82	4	CID000007895
Drug	alpha-methyldopamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.20e-06	26	82	4	CID000017005
Drug	glycolithocholic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.20e-06	26	82	4	CID000115245
Drug	1m2q	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.20e-06	26	82	4	CID005326637
Drug	4-hydroxyestrone	SULT1A2 SULT1A4 CYP2C18 SULT1A1 SULT1A3	2.30e-06	59	82	5	CID000018418
Drug	N-hydroxy-4-aminobiphenyl	SULT1A2 SULT1A1 SULT1A3	2.49e-06	8	82	3	ctd:C014593
Drug	Glu-P-2	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.47e-06	29	82	4	CID000049970
Drug	3,3'-T2	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.99e-06	30	82	4	CID000065559
Drug	barium hydroxide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.57e-06	31	82	4	CID000028387
Drug	X1043	FAP DPP10 DPP8	5.31e-06	10	82	3	CID011235728
Drug	DCNP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.91e-06	33	82	4	CID000012066
Drug	7-hydroxycoumarin	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	7.59e-06	75	82	5	CID005281426
Drug	benzyloxyresorufin	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	9.20e-06	78	82	5	CID000114982
Drug	4-hydroxyestradiol	SULT1A2 SULT1A4 CYP2C18 SULT1A1 SULT1A3	9.80e-06	79	82	5	CID000001743
Drug	phenylhydroxylamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-05	38	82	4	CID000007518
Drug	aniline	SULT1A2 SULT1A4 CYP2C9 CYP2C18 SULT1A1 SULT1A3	1.26e-05	142	82	6	CID000006115
Drug	5-hydroxymethylfurfural	SULT1A2 SULT1A1	1.28e-05	2	82	2	ctd:C008046
Drug	Hydroxytryptophol	SULT1A1 SULT1A3	1.28e-05	2	82	2	ctd:D006917
Drug	6-hydroxymelatonin	SULT1A1 SULT1A3	1.28e-05	2	82	2	ctd:C012365
Drug	d-equilenin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.43e-05	41	82	4	CID000010597
Drug	L-alpha-methyldopa	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.58e-05	42	82	4	CID000004138
Drug	Woodward's reagent K	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.73e-05	43	82	4	CID000077804
Drug	NSC674039	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.90e-05	44	82	4	CID000001249
Drug	1IIg	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.08e-05	45	82	4	CID000001682
Drug	NDPS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.08e-05	45	82	4	CID000090363
Drug	4-octylphenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.48e-05	47	82	4	CID000015730
Drug	salicylamide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.70e-05	48	82	4	CID000005147
Drug	N-hydroxy-2-acetylaminofluorene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.70e-05	48	82	4	CID000005896
Drug	1-naphthol	SULT1A2 SULT1A4 CYP2C9 SULT1A1 SULT1A3	2.80e-05	98	82	5	CID000007005
Drug	ginsenoside Rf	SLC6A7 CYP2C9 RB1	2.95e-05	17	82	3	CID000441922
Drug	6-hydroxymelatonin	SULT1A2 CYP2C9 CYP2C18 SULT1A1	3.17e-05	50	82	4	CID000001864
Drug	5-hydroxy-3-methylindole	SULT1A2 SULT1A1	3.84e-05	3	82	2	CID000192734
Drug	5-hydroxyindole	SULT1A1 SULT1A3	3.84e-05	3	82	2	ctd:C026785
Drug	Minoxidil	SULT1A1 SULT1A3	3.84e-05	3	82	2	ctd:D008914
Drug	8-azaadenine	SULT1A1 SULT1A3	3.84e-05	3	82	2	ctd:C006654
Drug	3,3'-diiodothyronine	SULT1A1 SULT1A3	3.84e-05	3	82	2	ctd:C030629
Drug	androstenediol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.31e-05	54	82	4	CID000010634
Drug	4-nitrophenol	SULT1A2 SULT1A4 CYP2C9 CSGALNACT2 SULT1A1 SULT1A3	4.35e-05	177	82	6	CID000000980
Drug	Triiodothyronine	CYP2C9 SULT1A1 SULT1A3 RB1 PLXNC1 SLC6A19 FGF1 CCNA2 HR	5.45e-05	477	82	9	ctd:D014284
Drug	diphenyl phosphonate	FAP DPP10 DPP8	5.71e-05	21	82	3	CID006327546
Drug	NSC36919	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.72e-05	58	82	4	CID000235496
Drug	acetaminophen glucuronide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.12e-05	59	82	4	CID000083944
Drug	tetraarsenic tetrasulfide	PDIA4 PRAM1 RB1 CCNA2	6.54e-05	60	82	4	ctd:C534735
Drug	glycylproline 4-nitroanilide	FAP DPP8	7.65e-05	4	82	2	ctd:C042892
Drug	Chebi:32701	SULT1A2 SULT1A1	7.65e-05	4	82	2	CID005460855
Drug	Bupleuran 2IIc	RB1 CCNA2	7.65e-05	4	82	2	ctd:C073829
Drug	phenylglyoxal	FAP SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.68e-05	121	82	5	CID000014090
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	MAGI2 COL8A1 ZBTB38 KHDRBS1 IRF4 DOP1A	7.89e-05	197	82	6	2556_UP
Drug	3-OHBaP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.92e-05	63	82	4	CID000025890
Drug	AC1O3UYX	SULT1A2 CYP2C9 SULT1A1 HR	7.92e-05	63	82	4	CID006338583
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ZBTB38 CYP2C9 CYP2C18 FGF1 OAS1 IRF4	8.11e-05	198	82	6	3831_UP
Drug	PhIP-HCl	SULT1A2 SULT1A4 SULT1A1 SULT1A3 RB1	8.30e-05	123	82	5	CID000001530
Drug	2-C5	CDSN CYP2C9 CYP2C18 GZMH	8.42e-05	64	82	4	CID005287467
Drug	4-nonylphenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.42e-05	64	82	4	CID000001752
Drug	epicatechin-3-gallate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.95e-05	65	82	4	CID000065056
Drug	Tolbutamide	CYP2C9 CYP2C18 RB1	9.78e-05	25	82	3	ctd:D014044
Drug	Pyrethroids	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.26e-04	71	82	4	CID000005053
Drug	harmol	SULT1A1 SULT1A3	1.27e-04	5	82	2	ctd:C001326
Drug	pinocembrin	SULT1A1 SULT1A3	1.27e-04	5	82	2	ctd:C016063
Drug	alanylproline-4-nitroanilide	FAP DPP8	1.27e-04	5	82	2	ctd:C083013
Drug	TKPP	SULT1A2 SULT1A1	1.27e-04	5	82	2	CID000023740
Drug	adenylylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.33e-04	72	82	4	CID000000228
Drug	cypermethrin	FAP DPP10 DPP8	1.38e-04	28	82	3	CID000002912
Drug	ValboroPro	FAP DPP10 DPP8	1.38e-04	28	82	3	CID006918572
Drug	diisopropylfluorophosphate	PDIA4 FAP DPP10 PLCXD2 GZMH CPE DPP8	1.60e-04	321	82	7	CID000005936
Drug	enterocin	SLC6A7 SULT1A2 SULT1A1	1.88e-04	31	82	3	CID000115182
Disease	Chromosome Aberrations	SULT1A2 SULT1A1 POT1	1.05e-05	16	80	3	C0008625
Disease	Autosome Abnormalities	SULT1A2 SULT1A1 POT1	1.05e-05	16	80	3	C0004403
Disease	X-21258 measurement	CYP2C9 CYP2C18	2.17e-05	3	80	2	EFO_0800802
Disease	urinary bladder cancer (is_implicated_in)	CYP2C9 SULT1A1 RB1 FGF1	5.54e-05	76	80	4	DOID:11054 (is_implicated_in)
Disease	pulmonary function measurement, forced expiratory volume	ZBTB38 MECOM ZKSCAN2	1.40e-04	37	80	3	EFO_0003892, EFO_0004314
Disease	embryonal carcinoma (is_marker_for)	RB1 CCNA2	1.51e-04	7	80	2	DOID:3308 (is_marker_for)
Disease	alopecia (is_implicated_in)	CDSN HR	1.51e-04	7	80	2	DOID:987 (is_implicated_in)
Disease	glycine conjugate of C10H14O2 (1) measurement	CYP2C9 CYP2C18	1.51e-04	7	80	2	EFO_0800655
Disease	Lymphoid leukemia	POT1 MECOM	2.01e-04	8	80	2	C0023448
Disease	alcohol consumption measurement, alcohol drinking	HECTD4 GCKR	4.71e-04	12	80	2	EFO_0004329, EFO_0007878
Disease	X-12707 measurement	SULT1A2 SULT1A1	4.71e-04	12	80	2	EFO_0800720
Disease	ascorbic acid 3-sulfate measurement	SULT1A2 SULT1A1	6.47e-04	14	80	2	EFO_0800173
Disease	Meckel-Gruber syndrome	TMEM216 WDPCP	7.45e-04	15	80	2	C0265215
Disease	myeloid white cell count	FAP HECTD4 MECOM IRF4 RP1 GCKR SPAG17 DTHD1 C3orf49	9.75e-04	937	80	9	EFO_0007988
Disease	Meckel syndrome type 1	TMEM216 WDPCP	1.08e-03	18	80	2	C3714506
Disease	metabolonic lactone sulfate measurement	CYP2C9 CYP2C18	1.20e-03	19	80	2	EFO_0800659
Disease	autoimmune disease	FAP PLXNC1 IRF4 PRRC2A	1.28e-03	173	80	4	EFO_0005140
Disease	creatinine measurement	FAP PLXNC1 SLC6A19 CPNE3 MECOM GCKR CCNA2 EEF1A2 TDRD12	1.48e-03	995	80	9	EFO_0004518
Disease	renal system measurement, blood urea nitrogen measurement	HECTD4 MECOM	1.62e-03	22	80	2	EFO_0004741, EFO_0004742
Disease	smoking status measurement, chronic obstructive pulmonary disease	THSD4 ZBTB38 MECOM	1.78e-03	88	80	3	EFO_0000341, EFO_0006527
Disease	body fat percentage	AGBL4 MAGI2 ZBTB38 SULT1A1 PRRC2A HR	2.12e-03	488	80	6	EFO_0007800

Protein segments in the cluster

Peptide	Gene	Start	Entry
PSGLFYILPFQKGYL	ACTR6	51	Q9GZN1
PPPVYTNGKKLDGIY	BPIFB4	71	P59827
LSYGNKKGTPPGVYI	GZMH	216	P20718
VGYFNTYKLLPPKNP	CPNE3	516	O75131
IYYLPLGKTLKPGLQ	DOP1A	131	Q5JWR5
GKIYPVGYFTKENPV	CDSN	316	Q15517
IPRFTGALYPKGKQY	DPP10	266	Q8N608
GGNIYISPLKSPYKI	RB1	801	P06400
KYYLKNSPDLGPIGG	PUM2	1046	Q8TB72
FTPKEGSPYKAPIYI	MECOM	56	Q03112
PLFKAKYFYITPGIC	PAXIP1	971	Q6ZW49
FPYLGEVKPGKVAYE	MAGI2	41	Q86UL8
PYKVYRIVPEGAKKG	IRF4	121	Q15306
LKAKPPYYVGLGVEA	ERVS71-1	306	P61550
VQKLYGFPYKIPAVV	DYNC1LI1	301	Q9Y6G9
LGSKGFYYKDPSIPR	HR	201	O43593
PDPVKNIYIYLTAGK	PLXNC1	431	O60486
LYQSPPGRYLSPKKG	PCDH8	1051	O95206
IFVIGFSYPVVPKGK	GCAT	371	O75600
GGYKPNPQIYVKLIE	OAS1	161	P00973
NKGKYILTPSPITYG	HECTD4	3681	Q9Y4D8
PPAIKLGFYAYLGVL	GPR35	16	Q9HC97
VPFTKNPEKYIKYGV	EXOC7	706	Q9UPT5
GPTKILLNYFGNYVP	PLOD2	256	O00469
KGLGQKPLYTYLIAG	GCKR	126	Q14397
KIFYYEIPGPINKTT	WDPCP	211	O95876
PGKKVFYPVVFSLYN	CSGALNACT2	386	Q8N6G5
LYLPEPFKIAYRKVG	C3orf49	6	Q96BT1
GAPGKVKQYLVTYTP	COL12A1	836	Q99715
SPVLGYKIVYKPVGS	COL12A1	2141	Q99715
GRNYGPPGTKKLVYF	DNAH17	2506	Q9UFH2
AYIKKIGYNPATVPF	EEF1A2	176	Q05639
PLQFYGTLPKGYVIK	CMYA5	241	Q8N3K9
LQPGKKYPTVLFIYG	DPP8	656	Q6V1X1
KKGPGPLATAYLVIY	HACD2	31	Q6Y1H2
SKYIVLPTGYCGQPK	AGBL4	26	Q5VU57
PGYLAITKKVAVPYS	CPE	426	P16870
RAIFTGYYGKGKPVP	CNP	391	P09543
FPPVGAPVKFNKLLY	COL8A1	626	P27658
PHYKGTIVVYKVPKG	DTHD1	611	Q6ZMT9
QYPKFNFVGKILGPQ	KHDRBS1	166	Q07666
AKSIIGVIPYFPYSK	PRPSAP2	101	O60256
YGPVFTVYFGLKPIV	CYP2C18	61	P33260
YGPVFTLYFGLKPIV	CYP2C9	61	P11712
PYLKYLPSVIAGAAF	CCNA2	346	P20248
KYGEALGIKYPVQVP	GTF2IRD1	716	Q9UHL9
IPPGKGSQYLRTKYN	UTP3	256	Q9NQZ2
QKPYPGYATKQKLAL	DUXA	36	A6NLW8
PFKPGNYDIQKYLLP	RP1	226	P56715
GPNIYELRTYKLKPG	NIPSNAP1	181	Q9BPW8
KYGTDLLLYRKGPPF	TSEN2	361	Q8NCE0
GVPSLTIPGYAIYKL	SLC6A19	591	Q695T7
GVSYKLNGKRIPYFP	ADSS1	376	Q8N142
VLGIYLYPLPKSVLG	SLC26A9	421	Q7LBE3
IRGAVPAPYYKLGKT	TCAF2	631	A6NFQ2
ALPSFGYIKIIPFYI	TDRD12	876	Q587J7
IVPVYYPQVGKPKLA	PPP1R42	276	Q7Z4L9
FNLPPGNYKKPKLLY	FGF1	16	P05230
DPKGKYGYVPRTALL	PRAM1	631	Q96QH2
YGVVKFFKPPYLSKG	POT1	26	Q9NUX5
SQGLGYPKYQKSLPP	PRRC2A	631	P48634
GYPTLKIFRKGRPYD	PDIA4	251	P13667
GKSLCFQYPPVYVGK	WRN	576	Q14191
FQYPPVYVGKIGLVI	WRN	581	Q14191
VSKKYLPFYLGLPGS	NPAP1	716	Q9NZP6
PLEYVKGVPLIKYFA	SULT1A4	11	P0DMN0
PLEYVKGVPLIKYFA	SULT1A3	11	P0DMM9
PYYLRPKKAVFSGLI	SLC6A7	416	Q99884
KAKKPVGGNAPLYYE	SPAG17	91	Q6Q759
QGYTKVPVPGYTKLP	SPRR3	136	Q9UBC9
SKKYPLLIQVYGGPC	FAP	531	Q12884
PGRGFVLYPVKYKAI	POLR2G	61	P62487
PFYKQYPFLWPGKKI	PLCXD2	216	Q0VAA5
PLEYVKGVPLIKYFA	SULT1A1	11	P50225
PLEYVKGVPLIKYFA	SULT1A2	11	P50226
PNGGYKPKLNTLKLY	ZBTB4	401	Q9P1Z0
LKFPAPGKPGNYQYT	SEC63	681	Q9UGP8
PFVGKRPYRLLKYGE	ZKSCAN2	741	Q63HK3
TANGGLKPSVYPYKL	ZBTB38	551	Q8NAP3
KYGYGKAPYILPLQT	THSD4	166	Q6ZMP0
KYEYKFGFELPQGPL	TXNIP	96	Q9H3M7
IFLYKGVLLPYPTAN	TMEM216	41	Q9P0N5
YVPYTGEKKGKIFIP	TMOD3	86	Q9NYL9
KLIYNEYCGPGAKPL	KIAA2013	611	Q8IYS2
IYSTSKAFIGPIYKP	N4BP2L2	116	Q92802